Grifols, SA
GRF
ISIN ES0171996087 / Valor 30689493
Grifols, SA
UMushroom community rating:
About company
Grifols, SA is a leading global healthcare company that specializes in plasma-derived medicines, biopharmaceuticals, and solutions in transfusion medicine. The company is known for its innovative products and services that enable millions of patients around the world to lead more productive lives. Grifols is also involved in the agglutination technique to determine blood groups and transfusion compatibility studies, using gel as a reagent in columns on cards. Additionally, the company is engaged in the preparation of intravenous medicines for fluid therapy, contributing to the healthcare industry with its expertise and commitment to improving patient outcomes.
Summarized from source with an LLMView SourceSector: TechnologyKey figures
Performance
Volatility
4067 M
Market cap (USD)
3,808,511
Daily traded volume (Shares)
9.186 / 9.04
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
